South Korea Percutaneous Coronary Intervention Market Research Report By Product Type (Coronary Stents, Ballon Catheters, Coronary Guidewires, Guiding Catheters, Guiding Sheaths, Diagnostic Catheters, Crossing Catheters, Inflation Device, Guidance System, Peripheral Thrombectomy System, Embolic Protection System, Accessories), By Vascular Access (Radial, Femoral) and By End User (Hospitals Clinics, Ambulatory Surgical Centers, Others)-Forecast to 2035

South Korea Percutaneous Coronary Intervention Market Overview

As per MRFR analysis, the South Korea Percutaneous Coronary Intervention Market Size was estimated at 212.67 (USD Million) in 2023.The South Korea Percutaneous Coronary Intervention Market is expected to grow from 234.0(USD Million) in 2024 to 486.0 (USD Million) by 2035. The South Korea Percutaneous Coronary Intervention Market CAGR (growth rate) is expected to be around 6.87% during the forecast period (2025-2035).

Key South Korea Percutaneous Coronary Intervention Market Trends Highlighted

The market for percutaneous coronary intervention (PCI) in South Korea is heavily impacted by the rising incidence of cardiovascular illnesses, which are mostly caused by aging populations and changes in lifestyle.

The government has taken the initiative to support early intervention techniques, advance treatment alternatives, and fortify the healthcare system. Initiatives promoting the use of PCI technology, which are essential in lowering the risk of serious cardiovascular events, demonstrate this focus on enhancing heart health.

As patients and healthcare professionals look to shorten recovery periods and hospital stays, recent trends indicate an increasing demand for less invasive procedures. Manufacturers are being prompted by this change to innovate and create cutting-edge catheter-based devices that improve patient outcomes and procedural efficiency.

Furthermore, the use of digital technology, like telemedicine, in follow-up care after PCI is becoming increasingly popular, which is indicative of a larger movement in healthcare delivery toward more patient-centered methods.

There are a lot of opportunities in the South Korean PCI industry, especially in the creation and launch of specialty devices for patients with complicated coronary artery disease or diabetes.

Furthermore, partnerships between healthcare organizations and device makers are growing in importance as a result of government investments in health technology, which makes it possible to introduce novel solutions.

To guarantee a competent workforce prepared to manage the changing landscape of cardiovascular treatments, improved training programs for medical professionals on the newest PCI procedures are also essential.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

South Korea Percutaneous Coronary Intervention Market Drivers

Increasing Prevalence of Cardiovascular Diseases

The South Korea Percutaneous Coronary Intervention Market is witnessing significant growth driven by the rising incidence of cardiovascular diseases (CVDs) in the region. According to the Korean Society of Cardiology, CVDs are responsible for approximately 30% of all deaths in South Korea, highlighting a critical public health issue.

Furthermore, the number of patients diagnosed with ischemic heart disease has seen an annual increase of 4-5%, leading to a higher demand for advanced treatment options such as percutaneous coronary interventions (PCI).

This surge in patient numbers is further supported by government initiatives aimed at reducing the mortality rates associated with CVDs, such as the National Cardiovascular Strategy, which was devised to improve the outcomes of cardiac patients and promote effective treatment modalities, thereby further augmenting the market growth for PCI services and devices in South Korea.

Technological Advancements in Interventional Cardiology

Technological advancements are playing a crucial role in the growth of the South Korea Percutaneous Coronary Intervention Market. Innovative devices and techniques, including drug-eluting stents and bioresorbable scaffolds, have significantly improved patient outcomes and reduced recovery times.

The Ministry of Health and Welfare in South Korea has noted that the adoption of these new technologies has led to a 16% decrease in post-procedure complications, encouraging more cardiologists to opt for PCI procedures as a first-line treatment. As healthcare providers continue to integrate cutting-edge technologies into their practices, the demand for PCI is likely to rise, further propelling market expansion.

Aging Population Driving Increased PCI Procedures

The aging population in South Korea is another significant driver of growth in the South Korea Percutaneous Coronary Intervention Market. By 2030, it is projected that over 20% of the South Korean population will be aged 65 and older, leading to a higher prevalence of age-related cardiovascular conditions.

The Korean Institute for Health and Social Affairs reported that individuals in this age group are twice as likely to experience coronary artery disease compared to younger demographics.

As a result, the healthcare system is expected to see an increase in the demand for PCI procedures to address these health issues, thereby boosting market growth and promoting further investments in cardiovascular care.

South Korea Percutaneous Coronary Intervention Market Segment Insights

Percutaneous Coronary Intervention Market Product Type Insights

The South Korea Percutaneous Coronary Intervention Market is a critical aspect of the country's healthcare industry, particularly in the context of cardiovascular diseases that significantly impact the population.

The dynamic and diverse landscape of this market can be understood through its various product types, including the likes of Coronary Stents, Balloon Catheters, and a range of other specialized devices.

Coronary Stents are pivotal as they provide structural support to keep arteries open following a PCI procedure, thereby reducing the risk of restenosis. The Balloon Catheters play a crucial role in the initial phase of angioplasty, facilitating the dilation of narrowed arteries, which is essential for enhancing blood flow.

Additionally, Coronary Guidewires and Guiding Catheters are indispensable tools that assist interventional cardiologists in maneuvering within the vascular system, ensuring precision during procedures.

The Guiding Sheaths are designed to allow for easier access while protecting the surrounding blood vessels, thus making PCI safer and more effective. Diagnostic Catheters are also vital as they enable healthcare professionals to assess the coronary arteries and identify blockages accurately, which is crucial for determining the appropriate intervention.

Moreover, Crossing Catheters and Inflation Devices hold significant importance by aiding in the delivery of therapies and ensuring the balloon is inflated to the correct pressure for optimal results. The Guidance Systems are becoming increasingly sophisticated, providing real-time imaging and assistance which improves procedural outcomes dramatically.

On the more advanced front, Peripheral Thrombectomy Systems and Embolic Protection Systems are essential in preventing complications such as thrombosis during interventions, underscoring their relevance in enhancing patient safety.

Accessories, though often overlooked, are integral to the functionality of PCI procedures, offering necessary support and tools for clinicians throughout the process.

The South Korea Percutaneous Coronary Intervention Market showcases growing innovations in product development, reflecting a broader trend of technological advancement in medical devices, especially towards minimally invasive solutions that promise reduced recovery times and improved patient outcomes.

The aging population and rising prevalence of cardiovascular conditions in South Korea are driving an increased demand for these products, creating an expansive opportunity for growth within the market. Additionally, the focus by the government on healthcare improvements and investments in medical technologies is further propelling the advancements within this segment.

Overall, each product type contributes to the comprehensive approach required to effectively address the challenges posed by coronary diseases in South Korea, which is reflected in the continued expansion and evolution of the South Korea Percutaneous Coronary Intervention Market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Percutaneous Coronary Intervention Market Vascular Access Insights

The Vascular Access segment in the South Korea Percutaneous Coronary Intervention Market plays a crucial role in facilitating effective and efficient procedures in the cardiovascular clinical setting. With advancements in technology, there has been an increasing preference for the radial access route, which is widely recognized for its reduced risk of complications compared to femoral access.

The ability to provide a more comfortable experience for patients and lower recovery times has led to its growing adoption among healthcare providers in South Korea.

On the other hand, femoral access continues to dominate certain clinical scenarios where larger sheath sizes are required, ensuring its relevance in complex procedures. The South Korean healthcare system is investing heavily in training and education around these techniques, which further supports the market's growth.

The high prevalence of cardiovascular diseases in the region underscores the importance of improving vascular access strategies as a component of the overall treatment landscape. Market trends show a shift towards less invasive methods, aligning with the global push for improved patient outcomes and safety within the South Korea Percutaneous Coronary Intervention Market.

Percutaneous Coronary Intervention Market End User Insights

The South Korea Percutaneous Coronary Intervention Market is shaped significantly by its End User segment, which includes Hospitals, Clinics, Ambulatory Surgical Centers, and Others. In South Korea, hospital clinics are vital as they provide comprehensive cardiac care and advanced procedural capabilities required in percutaneous interventions.

These facilities are typically well-equipped with the latest technologies and medical expertise, crucial in enhancing surgical outcomes. Ambulatory Surgical Centers emerge as a significant player, driven by the increasing preference for outpatient procedures that reduce hospital stays and facilitate faster recovery, ultimately reflecting a trend towards cost efficiency in healthcare delivery.

Additionally, the 'Others' category encapsulates various healthcare frameworks catering to diverse patient needs, including specialty clinics and rehabilitation centers, emphasizing a growing inclination towards integrated healthcare solutions.

Overall, the dynamics within the End User segment showcase a landscape that is increasingly aligned with patient-centric care approaches, contributing to the ongoing development of the South Korea Percutaneous Coronary Intervention Market.

South Korea Percutaneous Coronary Intervention Market Key Players and Competitive Insights

The South Korea Percutaneous Coronary Intervention Market is characterized by a dynamic landscape where various healthcare providers and medical device manufacturers compete to establish market presence and gain a competitive edge.

The increase in cardiovascular diseases and the growing aging population have driven the demand for advanced interventional cardiology procedures, creating opportunities for companies to innovate and expand their offerings.

As the healthcare system continues to evolve, strategic collaborations, technological advancements, and the introduction of new products play a pivotal role in shaping market competition. Companies in this domain are focusing on enhancing patient outcomes, improving procedural efficiency, and meeting regulatory standards to maintain their competitive advantage.

Understanding the competitive dynamics within this market is essential for stakeholders aiming to navigate the complexities of evolving healthcare demands. Terumo Corporation holds a significant position in the South Korea Percutaneous Coronary Intervention Market, owing to its strong manufacturing capabilities and commitment to quality.

The company is known for producing high-quality medical devices that are crucial for catheter-based interventions, including specialized guide wires, balloons, and stents tailored for cardiac procedures. Terumo Corporation's strengths lie in its robust research and development efforts, which enable continual innovation to meet the needs of healthcare professionals and patients alike.

Furthermore, the company has established a solid distribution network across South Korea, enhancing its ability to deliver products efficiently to hospitals and clinics. Terumo Corporation's commitment to education and training for healthcare professionals further solidifies its reputation in the market, as it invests in initiatives that promote best practices in the use of its technology.

Elekta is also a key player in the South Korea Percutaneous Coronary Intervention Market, although its focus primarily extends to innovative software solutions and advanced medical devices designed to aid in cancer treatment and other interventional procedures.

The company provides an array of products that facilitate enhanced imaging and navigation capabilities, which are vital for precise interventions in the cardiovascular domain. With a strong market presence bolstered by partnerships and collaborations with local healthcare institutions, Elekta capitalizes on its expertise in the radiation oncology sector to expand its reach within the cardiology market.

The company’s strengths lie in its commitment to research and development, which has led to several key innovations that support interventional cardiologists in their day-to-day practices. Elekta’s strategic approach to mergers and acquisitions also plays a vital role in augmenting its technological offerings, allowing it to integrate state-of-the-art solutions into its product line.

This multifaceted strategy helps Elekta maintain a competitive edge while navigating the complexities of the South Korean market.

Key Companies in the South Korea Percutaneous Coronary Intervention Market Include

• Terumo Corporation


• Elekta


• Johnson and Johnson


• Boston Scientific


• Siemens Healthineers


• CathRx


• Stryker Corporation


• B. Braun Melsungen


• Asahi Intecc


• Abbott Laboratories


• Medtronic


• C. R. Bard


• Cardinal Health


• AngioDynamics


• Cook Medical

South Korea Percutaneous Coronary Intervention Market Developments

Recent developments in the South Korea Percutaneous Coronary Intervention (PCI) market showcase significant activity among leading players. Companies like Terumo Corporation and Boston Scientific are focusing on technological advancements to enhance patient outcomes, with new products emerging that facilitate safer procedures.

In September 2023, Medtronic introduced an innovative stent that promises to reduce restenosis rates, marking a crucial step in PCI treatment.

Current affairs indicate a growing demand for PCI procedures in South Korea due to an aging population and rising cardiovascular disease prevalence, driving market valuation upward. Asahi Intecc and Abbott Laboratories are expanding their portfolios to cater to this demand, significantly impacting market dynamics.

In terms of mergers and acquisitions, Stryker Corporation announced the acquisition of CathRx in March 2023, aiming to enhance its product offerings in coronary intervention technologies. Such strategic moves illustrate the competitive landscape and the consolidation trend within the PCI sector.

Over the past two years, regulatory support from the South Korean government has contributed positively to market expansion with initiatives promoting healthcare innovation. This landscape fosters collaboration among key players, including Elekta, Johnson Johnson, and B. Braun Melsungen, further shaping the competitive environment.

South Korea Percutaneous Coronary Intervention Market Segmentation Insights

• Percutaneous Coronary Intervention Market Product Type Outlook


• Coronary Stents


• Ballon Catheters


• Coronary Guidewires


• Guiding Catheters


• Guiding Sheaths


• Diagnostic Catheters


• Crossing Catheters


• Inflation Device


• Guidance System


• Peripheral Thrombectomy System


• Embolic Protection System


• Accessories


• Percutaneous Coronary Intervention Market Vascular Access Outlook


• Radial


• Femoral


• Percutaneous Coronary Intervention Market End User Outlook


• Hospitals Clinics


• Ambulatory Surgical Centers


• Others

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	212.67(USD Million)
MARKET SIZE 2024	234.0(USD Million)
MARKET SIZE 2035	486.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	6.87% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Terumo Corporation, Elekta, Johnson and Johnson, Boston Scientific, Siemens Healthineers, CathRx, Stryker Corporation, B. Braun Melsungen, Asahi Intecc, Abbott Laboratories, Medtronic, C. R. Bard, Cardinal Health, AngioDynamics, Cook Medical
SEGMENTS COVERED	Product Type, Vascular Access, End User
KEY MARKET OPPORTUNITIES	Growing elderly population, Increasing prevalence of heart diseases, Advancements in catheter technology, Rising healthcare expenditure, Government support for healthcare innovations
KEY MARKET DYNAMICS	Increasing cardiovascular diseases, Technological advancements, Aging population, Rising healthcare expenditure, Government healthcare initiatives
COUNTRIES COVERED	South Korea